HomeIKT • NASDAQ
add
Inhibikase Therapeutics Inc
Previous close
$1.67
Day range
$1.60 - $1.75
Year range
$1.33 - $3.50
Market cap
207.95M USD
Avg Volume
404.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.61M | 242.67% |
Net income | -11.93M | -106.48% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -13.24M | -127.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.32M | 2,283.81% |
Total assets | 79.59M | 1,718.52% |
Total liabilities | 6.70M | 36.45% |
Total equity | 72.90M | — |
Shares outstanding | 71.03M | — |
Price to book | 1.62 | — |
Return on assets | -39.36% | — |
Return on capital | -43.34% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.93M | -106.48% |
Cash from operations | -10.59M | -117.02% |
Cash from investing | -28.75M | -1,237.96% |
Cash from financing | -134.13K | -173.72% |
Net change in cash | -39.47M | -1,716.49% |
Free cash flow | -5.89M | -139.86% |
About
Founded
2008
Headquarters
Website
Employees
15
